8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
DaVita filed an 8‑K on Feb 2, 2026 disclosing a press release (Ex.99.1) announcing financial results for…
Filed with the SEC on · Summarized by InvestorsBot
DaVita filed an 8‑K on Feb 2, 2026 disclosing a press release (Ex.99.1) announcing financial results for the quarter ended Dec 31, 2025. Investors should review the release for revenue, EPS and guidance. 🏥 $DVA #earnings #SECfiling
The 8‑K includes an Inline XBRL cover page (Ex.104.0). Report signed by Christopher M. Berry, Chief Accounting Officer, dated Feb 2, 2026 — XBRL provides machine‑readable financials for analysis. 🔍 $DVA #healthcare #XBRL
Action: Read DaVita’s Feb 2 press release and XBRL to assess Q4/FY2025 performance, cash flow and any guidance or notes that could affect estimates. 📈 $DVA #investing #earnings